The Chairman of the Sudan Sovereignty Committee and the Turkish President made a phone call focusing on the situation in Sudan. On December 13th, local time, Borhan, Chairman of the Sudan Sovereignty Committee and Commander-in-Chief of the Armed Forces, made a phone call with Turkish President Erdogan, focusing on the situation in Sudan. Erdogan said during the call that Turkey is willing to mediate between Sudan and the United Arab Emirates to resolve the contradictions between the two countries. Since the outbreak of armed conflict in Sudan last year, Sudanese government officials have repeatedly accused the UAE government of supporting the Sudan Rapid Support Force, which has caused tension between the two countries. At the end of last year, the two countries expelled each other's diplomats. Erdogan also said that Turkey opposes foreign interference in Sudan's internal affairs and supports Sudan in safeguarding national unity and territorial integrity and restoring peace and stability. (CCTV News)Trina Solar, the National Green Development Fund and Jianxin Trust jointly established the Double Carbon Industry Fund. On December 12th, the signing ceremony of Trina Solar's strategic cooperation with China Construction Bank and the conference of "Building a New Xingyuan Green Double Carbon Industry Fund" were held in Changzhou. The "New Xingyuan Green Double Carbon Industry Fund" was jointly established by Trina Solar, the National Green Development Fund and Jianxin Trust, and will focus on investing in clean energy fields such as photovoltaic, energy storage and hydrogen energy, as well as industries such as green manufacturing, energy-saving and carbon-reducing new materials.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.
Putin signed a decree to extend the measures to counter the western oil price limit against Russia again. On December 13th, local time, according to the documents published on the Russian legal information portal, Russian President Vladimir Putin has signed an order to extend the special economic measures formulated because western countries impose price limits on Russian oil and petroleum products until June 30th, 2025. Since the law came into effect on February 1, 2023, the validity of the measures has been extended several times. The decree stipulates that if the contract directly or indirectly stipulates the price ceiling set by other countries, it is forbidden to export Russian petroleum and petroleum products according to the contract, and the signed ban applies to all supply stages before delivery to buyers. (CCTV News)Macron rejected our proposal and appointed one of his allies as Prime Minister. We will not enter the government, and Macron chooses to continue his policy.Contemporary Amperex Technology Co., Limited traded 175,000 shares today with a turnover of 44,625,200 yuan, while Contemporary Amperex Technology Co., Limited traded 175,000 shares today with a turnover of 44,625,200 yuan, accounting for 0.58% of the total turnover of the day. The average transaction price was 255 yuan, which was 4.51% lower than the market closing price of 267.03 yuan, of which the highest transaction price was 267.03 yuan and the lowest transaction price was 218.97 yuan.
Huitai Medical: Using raised funds and self-owned funds to increase capital of 700 million yuan to wholly-owned subsidiaries. Huitai Medical announced that the company held the 20th meeting of the second board of directors and the 17th meeting of the second board of supervisors on December 12, 2024, and reviewed and approved the Proposal on Using raised funds and self-owned funds to increase capital to wholly-owned subsidiaries. The company agreed to increase its capital by 700 million yuan to Shanghai Hongtong Industrial Co., Ltd., a wholly-owned subsidiary, of which 438 million yuan of interest-bearing loans provided to Shanghai Hongtong with raised funds were converted into capital increase, and 262 million yuan was increased with its own funds. After the capital increase is completed, the registered capital of Shanghai Hongtong will increase from RMB 18,489,300 to RMB 26,548,200, and it will remain a wholly-owned subsidiary of the company.Huangshan Capsule: It is planned to distribute a cash dividend of 0.27 yuan for every 10 shares. Huangshan Capsule announced that the company held the board of directors and the board of supervisors on December 13, 2024, and reviewed and approved the profit distribution plan for the first three quarters of 2024. According to the plan, the company plans to distribute a cash dividend of RMB27 to all shareholders for every 10 shares based on the existing total share capital of 299 million shares, with a total cash dividend of RMB8,075,700. This profit distribution will not send bonus shares, and capital reserve will not be converted into share capital.Senior EU officials: The foreign ministers of 27 EU countries will approve the 15th round of sanctions against Russia and new sanctions "against hybrid operations" on December 16th.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14